News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Joe Y Chang: Intensity-modulated proton vs photon therapy with concurrent chemo in medical inoperable stage III NSCLC
Sep 29, 2024, 15:21

Joe Y Chang: Intensity-modulated proton vs photon therapy with concurrent chemo in medical inoperable stage III NSCLC

Joe Y Chang, Professor and Director, Stereotactic Ablative Radiotherapy Program, MD Anderson Cancer Center, shared a post on X:

“MD Anderson finished all enrollment of phase II randomized study comparing intensity-modulated proton vs photon therapy with concurrent chemo in medical inoperable stage III NSCLC.

I am lucky enough to enroll the last pt and received a nice bottle of wine from Zhongxing Liao.”

Joe Y Chang: Intensity-modulated proton vs photon therapy with concurrent chemo in medical inoperable stage III NSCLC

Source: Joe Y Chang/X

cancer cancer awareness cancer care fight against cancer Global fight against cancer Joe Y Chang MD Anderson Cancer Center NSCLC OncoDaily Oncology Zhongxing Liao
Special Coverage
Blog
Jan 27, 2025, 07:29
Potential of blood tests as a less invasive alternative to colonoscopy for diagnosis - American Society of Clinical Oncology
Science
Jan 27, 2025, 07:25
Claudin-18.2: Why Claudin-18.2 expression matters
Blog
Jan 27, 2025, 07:20
Dhan Chand: BOT + BAL is redefining the treatment paradigm in colorectal cancer
Blog
Jan 27, 2025, 07:17
Evandro de Azambuja: Few days to our BSMO Annual Meeting
Insight
Jan 27, 2025, 06:47
The EIOC Journal Club virtual roundtable discussion
Dialogues
Jan 27, 2025, 05:00
BGICC25 Updates: Dr. Joseph Gligorov on Breast Cancer Advances
Blog
Jan 27, 2025, 04:55
Douglas Flora: As someone who's both treated cancer patients and survived cancer myself, I know first hand that progress can't afford to wait
Opinion
Jan 27, 2025, 04:40
5 articles suggested by Wafik El-Deiry
Science
Jan 26, 2025, 21:58
Nikolas Naleid: Excited to share our systematic review on pembrolizumab safety in GI cancers
Science
Jan 26, 2025, 21:58
David J. Benjamin: Why did sacituzumab govitecan fail in the TROPiCS-04 study for advanced urothelial carcinoma?
Science
Jan 26, 2025, 21:58
Fumiko Ladd Chino: Developing a simplified financial toxicity screening tool for use in clinical practice
Blog
Jan 26, 2025, 21:56
Wafaa M Rashed: Developing localized guidelines that reflect the continent's cultural, social and economic contexts